Clinical Diagnostic PathologyClient: Independent Diagnostic Network (5 Central Labs + 22 Collection Points) • Timeline: 6 Months End-to-End Roadmap
NABL ISO 15189 Accreditation Advisory for Regional Diagnostic Network
The Institutional Challenge
The laboratory network suffered from recurrent sample rejection rates (4.8%), lack of internal quality control documentation (IQC/EQAS), and failed a preliminary NABL audit.
The SAF Corporate Solution
SAF Corporate consultants conducted exhaustive gap audits, instituted strict pre-analytical barcodes, calibrated all spectrophotometers and cell counters, rewrote the quality manual, and trained 48 phlebotomists and technologists in NABL documentation.
“Without SAF Corporate's meticulous gap analysis and relentless technician retraining, achieving our NABL seal would have taken years. They transformed our entire operational culture.”
Dr. (Col.) P. K. Singh
Chief Pathologist & Managing Director, Apex Clinical Diagnostics
Verified Outcome Metrics
From 4.8% to 0.4%
Sample Rejection Reduced
99.1%
EQAS Z-Score Reliability
Zero Major Non-Conformances
Final Audit Clearance
+52% in 12 Months
Revenue Growth Post-NABL
Enterprise Partnership
Transform Your Clinical Operations
Contact our Strategy Directorate to discuss your requirements.